SCHEMBL7196813

SCHEMBL7196813

NC(=O)[C@@H](N)CCS

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4632678 1.00 — —
SCHEMBL14956926 0.82 ALOX15 (0.43) —
SCHEMBL17541311 0.82 ALOX15 (0.43) —
SCHEMBL15676365 0.82 ALOX15 (0.43) —
SCHEMBL23318502 0.80 FOLH1 (0.42) —
SCHEMBL8430872 0.78 — —
Homocysteine SCHEMBL936365 0.78 PTGS1 (0.62) —
Homocysteine SCHEMBL35836 0.78 — —
Homocysteine SCHEMBL601148 0.78 — —
L-Homocysteine SCHEMBL936366 0.78 PTGS1 (0.62) —

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 12 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4610269-A1 UROKINASE PLASMINOGEN ACTIVATOR SURFACE RECEPTOR (UPAR) LIGANDS FOR DIAGNOSTIC OR THERAPEUTIC USE 3B Pharmaceuticals GmbH (DE) 2025-09-03 — — EP claimed
WO-2014066506-A2 COMPOSITIONS AND METHODS FOR JAMM PROTEIN INHIBITION CLEAVE BIOSCIENCES, INC. (US) 2014-05-01 — — WO claimed
WO-2013004716-A1 PEPTIDE BEADS UNIVERSITÄT BASEL (CH) 2013-01-10 — — WO claimed
US-6589751-B2 Antibody specific for homocystamide adducts, such as those formed by dehydrating homocysteine to homocysteine thiolactone and reaction this with a carrier such as low density lipoprotein (LDL) to form homocystamide-LDL adduct MCW RESEARCH FOUNDATION 2003-07-08 — — US claimed
EP-4610269-A1 UROKINASE PLASMINOGEN ACTIVATOR SURFACE RECEPTOR (UPAR) LIGANDS FOR DIAGNOSTIC OR THERAPEUTIC USE 3B Pharmaceuticals GmbH (DE) 2025-09-03 — — EP disclosed
US-11629171-B2 Beta-hairpin peptidomimetics SPEXIS AG (CH) 2023-04-18 — — US disclosed
CN-112334166-A Hydrogel compositions comprising crosslinked polymers 克罗马药品有限责任公司 2021-02-05 — — CN disclosed
CN-112334167-A Hydrogel compositions comprising crosslinked polymers 克罗马药品有限责任公司 2021-02-05 — — CN disclosed
WO-2014066506-A2 COMPOSITIONS AND METHODS FOR JAMM PROTEIN INHIBITION CLEAVE BIOSCIENCES, INC. (US) 2014-05-01 — — WO disclosed
WO-2013004716-A1 PEPTIDE BEADS UNIVERSITÄT BASEL (CH) 2013-01-10 — — WO disclosed
US-20110280802-A1 Linkers For Radiopharmaceutical Compounds BRACCO IMAGING S.P.A. (IT) 2011-11-17 — — US disclosed
US-20110250133-A1 GASTRIN RELEASING PEPTIDE COMPOUNDS BRACCO IMAGING S.P.A. (IT) 2011-10-13 — — US disclosed
Send feedback